Scarica l'app Stockscreener
1.43
2.88%
0.04
Dopo l'orario di chiusura:
1.39
-0.04
-2.80%
Precedente Chiudi:
$1.39
Aprire:
$1.41
Volume 24 ore:
331.39K
Relative Volume:
0.44
Capitalizzazione di mercato:
$44.84M
Reddito:
-
Utile/perdita netta:
$-69.00M
Rapporto P/E:
-0.5144
EPS:
-2.78
Flusso di cassa netto:
$-55.26M
1 W Prestazione:
+5.93%
1M Prestazione:
+7.52%
6M Prestazione:
-73.76%
1 anno Prestazione:
-82.92%
Intervallo 1D:
$1.34
$1.47
Intervallo di 1 settimana:
$1.34
$1.495
Portata 52W:
$1.05
$10.16
Acrivon Therapeutics Inc Stock (ACRV) Company Profile
Nome
Acrivon Therapeutics Inc
Settore
Industria
Telefono
617-207-8979
Indirizzo
480 ARSENAL WAY, SUITE 100, WATERTOWN
Confronta ACRV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics Inc
|
1.43 | 43.58M | 0 | -69.00M | -55.26M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-05 | Ripresa | Piper Sandler | Overweight |
| 2025-01-31 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-09-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2024-04-29 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-01 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-12-15 | Ripresa | Jefferies | Buy |
| 2023-10-05 | Iniziato | Maxim Group | Buy |
| 2023-06-02 | Iniziato | Oppenheimer | Outperform |
| 2023-05-08 | Iniziato | BMO Capital Markets | Outperform |
| 2023-04-27 | Iniziato | Ladenburg Thalmann | Buy |
| 2023-04-20 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-12 | Iniziato | Cowen | Outperform |
| 2022-12-12 | Iniziato | Jefferies | Buy |
| 2022-12-12 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Acrivon Therapeutics Inc Borsa (ACRV) Ultime notizie
When is Acrivon Therapeutics Inc. stock expected to show significant growthUnlock real-time stock alerts for quick profits - jammulinksnews.com
What are Acrivon Therapeutics Inc. company’s key revenue driversOverwhelming profit margins - jammulinksnews.com
How does Acrivon Therapeutics Inc. generate profit in a changing economyInvest confidently with real-time updates - jammulinksnews.com
What are the technical indicators suggesting about Acrivon Therapeutics Inc.Build wealth faster with high-performing stocks - jammulinksnews.com
Should I hold or sell Acrivon Therapeutics Inc. stock in 2025Exceptional trading results - jammulinksnews.com
What institutional investors are buying Acrivon Therapeutics Inc. stockFastest-growing stock picks - jammulinksnews.com
How strong is Acrivon Therapeutics Inc. company’s balance sheetHigh-yield trading alerts - jammulinksnews.com
What makes Acrivon Therapeutics Inc. stock price move sharplyFree High-Profit Stock Picks - Newser
What are the latest earnings results for Acrivon Therapeutics Inc.Capitalize on emerging market sectors - jammulinksnews.com
Is Acrivon Therapeutics Inc. stock a good hedge against inflationSafe and Smart Investment Picks - Newser
What are analysts’ price targets for Acrivon Therapeutics Inc. in the next 12 monthsDiscover high-impact investment opportunities - jammulinksnews.com
Published on: 2025-07-27 15:59:55 - jammulinksnews.com
Is Acrivon Therapeutics Inc. stock overvalued or undervaluedAccess high-yield investment alerts now - jammulinksnews.com
What is the dividend policy of Acrivon Therapeutics Inc. stockGet timely market insights for better trades - jammulinksnews.com
Acrivon Therapeutics Inc. Stock Analysis and ForecastBreakthrough profits - PrintWeekIndia
How high can Acrivon Therapeutics Inc. stock price go in 2025Free Group Entry - Newser
What analysts say about Acrivon Therapeutics Inc. stockRapid wealth creation - jammulinksnews.com
Is Acrivon Therapeutics Inc. a good long term investmentHigh-octane investment gains - jammulinksnews.com
Here's Why We're Watching Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation - Yahoo Finance
What drives Acrivon Therapeutics Inc. stock priceHigh-profit capital plays - jammulinksnews.com
Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionFree Insider Trading Tips - beatles.ru
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Rating of “Buy” from Analysts - Defense World
Analysts Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $17.71 - Defense World
Acrivon Therapeutics Inc Azioni (ACRV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):